NVCR 17.73 (+3.74%)
JE00BYSS4X48• Medical Devices & Instruments• Medical Instruments & Supplies
Intro Numbers Peers
  1. Home
  2. /
  3. All Stocks
  4. /
  5. NVCR

NovoCure (NVCR) Competitor Comparison

We are evaluating the key criteria listed to compare NovoCure (NVCR) against its competitors in the Medical Instruments & Supplies industry.

Market Capitalization

23 / 44

Gross Profits

19 / 40

Total Revenue

21 / 43

EBITDA

44 / 44

Free Cashflow

14 / 44

Quick Ratio

5 / 44

Earnings per Share

34 / 44

Dividend yield

0 / 13

Total Cash

7 / 44

Performance 3 years

39 / 44

Performance 5 years

37 / 44

Performance 10 years

29 / 44

Linearity 3 years

34 / 44

Linearity 5 years

30 / 44

Linearity 10 years

3 / 44

Total Rank

20 / 44

Dividend Rank

31 / 44

Valuation Rank

26 / 44

Piotroski Rank

23 / 44

Muliplier Rank

19 / 44

Performance 3 years - NVCR ranking 39 / 44

These are the competitors of NovoCure in the industry Medical Instruments & Supplies ranked by performance 3 years
1. Glaukos GKOS
189.06
2. Pro-Dex PDEX
105.59
3. LeMaitre Vascular LMAT
102.74
4. Intuitive Surgical ISRG
57.43
5. Haemonetics HAE
51.47
6. Merit Medical Systems MMSI
50.86
7. Bausch & Lomb BLCO
7.08
8. KORU Medical Systems KRMD
6.23
9. Hologic HOLX
5.18
10. Alcon ALC
4.52
11. Cooper Companies COO
-0.17
12. Ansell PD1.F
-5.35
13. ResMed RMD
-6.61
14. Steris STE
-7.68
15. Becton, Dickinson BDX
-9.45
16. electroCore ECOR
-13.06
17. Pulse Biosciences PLSE
-25.3
18. NexGel NXGL
-25.68
19. iRhythm Technologies IRTC
-26.92
20. West Pharmaceutical Services WST
-29.54
21. ICU Medical ICUI
-31.64
22. Atrion ATRI
-34.64
23. Teleflex TFX
-40.43
24. Utah Medical Products UTMD
-44.15
25. Masimo MASI
-44.33
26. Envista Holdings NVST
-49.43
27. BioLife Solutions BLFS
-49.92
28. Repligen RGEN
-50.15
29. AtriCure ATRC
-54.06
30. Warby Parker WRBY
-57.74
31. Baxter BAX
-58.17
32. OraSure Technologies OSUR
-60.47
33. Dentsply Sirona XRAY
-64.59
34. Harvard Bioscience HBIO
-71.08
35. Staar Surgical STAA
-75.83
36. AngioDynamics ANGO
-75.92
37. Nephros NEPH
-79.59
38. Ekso Bionics Holdings EKSO
-79.88
39. NovoCure NVCR
-83.57
40. Akoya Biosciences AKYA
-83.62
41. Microbot Medical MBOT
-87.69
42. Femasys FEMY
-92.74
43. NeuroMetrix NURO
-92.88
44. Predictive Oncology POAI
-95.59
Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.